📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Lotus Pharmaceutical Co Ltd
Lotus Pharmaceutical's GHG Emissions Data Preview
In 2024, Lotus Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Lotus Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Lotus Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Lotus Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Insights into Lotus Pharmaceutical's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofLotus Pharmaceutical amounted to15,515.044metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Lotus Pharmaceuticalincreased by 0.49%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
Lotus Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Lotus Pharmaceutical's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Lotus Pharmaceutical were 2,672.054 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Has Lotus Pharmaceutical reduced its Scope 1 emissions over time?
Since 2022, Lotus Pharmaceutical's Scope 1 emissions have decreased by 74.94%, reflecting a declining long-term trend in Scope 1 emissions over time.a
Compared to the previous year(2023), Lotus Pharmaceutical's Scope 1 emissions decreased by 19.28%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
What are Lotus Pharmaceutical's Scope 2 emissions?
In 2024, Lotus Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 12,842.99 tCOâ‚‚e without specifying the calculation method.a
Has Lotus Pharmaceutical reduced its Scope 2 emissions over time?
Since 2022, Lotus Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method)have increased by 20.63%, reflecting a rising long-term trend in Scope 2 emissions over time.a
Compared to the previous year(2023), Lotus Pharmaceutical's Scope 2 emissions(Unspecified Calculation Method) have remained relatively stable, indicating that Lotus Pharmaceutical's emissions have plateaued with no significant change in its energy consumption footprint.a
What methodology does Lotus Pharmaceutical use for Scope 2 reporting?
In 2024, Lotus Pharmaceutical reported its Scope 2 emissions using an unspecified methodology.a
Lotus Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Lotus Pharmaceutical’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Lotus Pharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 2,672.054 tCOâ‚‚e and total revenues of USD 567 millions. This translates into an emissions intensity of 4.71 tCOâ‚‚e per millions USD.a
Lotus Pharmaceutical's Scope 1 Emissions Intensity Compared to Peers
How does Lotus Pharmaceutical's GHG emissions intensity compare to its peers?
In 2024, Lotus Pharmaceutical reported a Scope 1 emissions intensity of 4.71 tCOâ‚‚e per millions USD. Compared to the peer group median of 18.32, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Lotus Pharmaceutical rank on GHG emissions intensity within its industry?
In 2024, Lotus Pharmaceutical ranked 5 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places Lotus Pharmaceutical among the top performers, with one of the lowest emissions intensities relative to peers.a